Welcome!

iPhone Authors: Scott Hirsch, Carmen Gonzalez, JP Morgenthal, David H Deans, Lori MacVittie

News Feed Item

Roche anuncia la indicación de marca CE expandida para la prueba del VPH cobas® 4800

- Roche anuncia la indicación de marca CE expandida para la prueba del VPH cobas® 4800 apoyando su uso para la exploración primaria del cáncer cervical  

-- La detección del ADN del VPH encuentra la enfermedad que no detecta la citología Pap

PLEASANTON, California, 28 de noviembre, 2012 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) ha anunciado hoy una indicación de marca CE expandida para la prueba del VPH cobas® 4800. La indicación recientemente expandida para la prueba del VPH cobas® 4800 como exploración primaria significa que ya no se requiere la citología Pap como un test conjunto o previo en países que acepten una marca CE. La infección persistente con el papilomavirus humano es la principal causa de cáncer cervical en mujeres. La indicación expandida está respaldada por los datos que se presentarán en la International Papillomavirus Conference, del 30 de noviembre al 6 de diciembre de 2012, en San Juan, Puerto Rico.

"La prueba del VPH ofrece un nivel más sensible de exploración que la prueba Pap. Mientras que la citología busca células anormales, una prueba VPH busca la presencia de ADN del VPH", dijo Eduardo Franco, director, de la División de Epidemiología del Cáncer, McGill University, Montreal, Canadá. "La prevalencia de VPH significa que muchas mujeres pueden tener resultado positivo, de modo que es importante identificar también las que más riesgo tienen de progresar a un cáncer cervical. La genotipificación para los tipos de VPH 16 y 18 ofrece una especificidad adicional suficiente para identificar a las mujeres de más riesgo y ahorra al resto posibles intervenciones innecesarias. Los dos genotipos de VPH, 16 y 18, suponen el 70% de los casos del cáncer cervical".

La prueba del ADN del HPV se ha utilizado más tradicionalmente como una co-prueba o test reflejo para un resultado citológico anormal o límite. Mientras que la exploración citológica ha reducido drásticamente la prevalencia de cáncer cervical en las últimas décadas, tiene limitaciones debido a la baja sensibilidad y la naturaleza subjetiva de la interpretación de los resultados. Sin embargo, los estudios muestran que la prueba del ADN del VPH es más sensible que la citología al detectar enfermedad, algo importante en una exploración de primera línea. En el estudio de referencia ATHENA, se muestra que la prueba del VPH cobas® 4800 encuentra enfermedad que no detecta la citología: 1 de cada 10 mujeres que dieron positivo en los genotipos de VPH 16 y 18 por la prueba del VPH cobas® 4800 de Roche ya presentaban evidencia de pre-cáncer cervical, aunque la citología fuera normal.  

Aproximadamente 275.000 mujeres en el mundo mueren de cáncer cervical cada año, y muchos países están en proceso de realizar pruebas de ADN del VPH como una sustitución para la citología. "Pasar al uso de la prueba del VPH cobas® 4800 como exploración primaria permite a los países implementar estrategias que detecten más enfermedad con menos intervenciones médicas, permite a los médicos tratar mejor a sus pacientes y reduce el coste económico para el sistema sanitario", dijo Paul Brown, jefe de Roche Molecular Diagnostics.

La prueba del VPH cobas® 4800 es la única prueba aprobada por la FDA validada clínicamente que simultáneamente proporciona resultados sobre los conocidos genotipos "de alto riesgo" y resultados individuales sobre los genotipos de mayor riesgo, HPV 16 y HPV 18, dando tres resultados en solo una prueba. La prueba del VPH cobas® 4800 tiene un proceso del flujo de trabajo de preparación de muestra totalmente automatizado, y funciones de eficiencia únicas que permite un mayor rendimiento, haciéndolo adecuado para programas de exploración de alto volumen.

"Como organización comprometida con la salud de la mujer, Roche Diagnostics se dedica a mantener a las mujeres sanas y mejorar el cuidado a los pacientes", dijo Paul Brown. "Combinada con nuestros productos desde la adquisición empresarial de mtm anunciada el año pasado, Roche cuenta con una amplia cartera de prevención del cáncer cervical que redefine la exploración del cáncer cervical y asesora con más efectividad sobre las decisiones de tratamiento a pacientes". 

Conferencia internacional sobre el virus del papiloma
Roche presentará los datos que respaldan la indicación expandida de la prueba de VPH cobas® 4800 así como la cartera del cáncer cervical más amplia de Roche en la Conferencia Internacional del Virus del Papiloma, del 30 de noviembre al 6 de diciembre de 2012 en San Juan, Puerto Rico.

Roche Satellite Symposium:  Translating Science into Primary Screening Practice
Lunes, 3 de diciembre, 12:30 PM1:45 PM, Puerto Rico Convention Center, Ballroom B

Primary HPV screening: Impact of varying the age of initiation on the performance of screening
Wright TC, Cox JT, Sharma A, Apple R, Behrens CM
Martes, 4 de diciembre, 2:00PM - 3:30PM, Room 208

3 Year cumulative incidence rates for high-grade cervical disease: Interim analysis from the ATHENA study
Castle PE, Wright TC, Stoler, MH, Zhang, Behrens CM
Martes, 4 de diciembre, 2:00PM- 3:30PM, Room 208

Intra-laboratory variation in the performance of liquid-based cytology; insights from ATHENA
Stoler MH, Wright TC, Apple R, Sharma A, Behrens CM
Martes, 4 de diciembre, 5:30PM - 7:30PM (Poster Session)

Acerca del estudio ATHENA
El estudio ATHENA de referencia de Roche para la prueba cobas® 4800 HPV es el mayor estudio de registro basado en EE.UU. para la exploración del cáncer cervical, incluyendo más de 47.000 mujeres.  

Acerca de la prueba de VPH cobas® 4800 y el sistema cobas® 4800

La prueba de VPH cobas® 4800 es una prueba cualitativa in vitro para detectar el virus del papiloma humano (VPH) en muestras de pacientes. La prueba utiliza la amplificación del ADN diana mediante reacción en cadena de la polimerasa (PCR) y la hibridación de ácidos nucleicos para detectar en un único análisis catorce genotipos de VPH de alto riesgo; identifica específicamente 14 tipos de VPH de alto riesgo, y al mismo tiempo detecta genéricamente los otros genotipos de alto riesgo (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 y 68). Actualmente está disponible en los EE.UU. y en todos los países que reconocen la marca CE.

El sistema cobas® 4800 está diseñado para ofrecer nuevos niveles de eficiencia analítica y relevancia diagnóstica. El sistema ofrece una automatización completa que no requiere la presencia de un operador y puede realizar hasta 282 pruebas en menos de 12 horas, lo que permite un análisis rápido de pruebas de cribado de infección por VPH que satisface las necesidades de la mayoría de laboratorios de análisis clínicos.

Acerca del virus del papiloma humano y el cáncer cervical
La infección persistente por el virus del papiloma humano (VPH) es la causa principal del cáncer de cuello de útero (cáncer cervical) en las mujeres; el VPH está implicado en más del 99% de los casos en todo el mundo. Según el Instituto Nacional del Cáncer estadounidense, cada año se dan en ese país 12.200 nuevos casos de cáncer cervical y se producen 4.210 fallecimientos por esa enfermedad. La Organización Mundial de la Salud estima que en todo el mundo son unos 470.000 los nuevos casos de cáncer cervical cada año.

Acerca de Roche
Roche, cuya sede central se halla en Basilea (Suiza), es una compañía líder del sector de la salud, centrada en la investigación y con la potencia combinada de la integración farmacéutica-diagnóstica. Roche es la mayor empresa biotecnológica del mundo y tiene medicamentos auténticamente diferenciados en las áreas de oncología, virología, inflamación, metabolismo y sistema nervioso central. Roche también es el líder mundial en diagnóstico in vitro, incluido el diagnóstico histológico del cáncer, y pionero en el control de la diabetes. La estrategia de Roche en medicina personalizada tiene como fin proporcionar medicamentos y herramientas diagnósticas que hagan posible mejoras tangibles de la salud, la calidad de vida y la esperanza de vida de los pacientes. En el año 2011, Roche tenía más de 80.000 empleados en todo el mundo e invirtió más de 9.000 millones de francos suizos en investigación y desarrollo. Las ventas alcanzaron la cifra de 42.500 millones de francos suizos. Genentech (Estados Unidos) es un miembro de plena propiedad del Grupo Roche. Roche posee una participación mayoritaria en Chugai Pharmaceutical (Japón). Para más información: www.roche.com.

Todas las marcas comerciales utilizadas o mencionadas están protegidas por la ley.

Para consultas de medios, contacte:
888-545-2443

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
The Internet of Things will greatly expand the opportunities for data collection and new business models driven off of that data. In her session at Internet of @ThingsExpo, Esmeralda Swartz, CMO of MetraTech, will discuss how for this to be effective you not only need to have infrastructure and operational models capable of utilizing this new phenomenon, but increasingly service providers will need to convince a skeptical public to participate. Get ready to show them the money! Speaker Bio: Esmeralda Swartz, CMO of MetraTech, has spent 16 years as a marketing, product management, and busin...
Samsung VP Jacopo Lenzi, who headed the company's recent SmartThings acquisition under the auspices of Samsung's Open Innovaction Center (OIC), answered a few questions we had about the deal. This interview was in conjunction with our interview with SmartThings CEO Alex Hawkinson. IoT Journal: SmartThings was developed in an open, standards-agnostic platform, and will now be part of Samsung's Open Innovation Center. Can you elaborate on your commitment to keep the platform open? Jacopo Lenzi: Samsung recognizes that true, accelerated innovation cannot be driven from one source, but requires a...
SYS-CON Events announced today that Red Hat, the world's leading provider of open source solutions, will exhibit at Internet of @ThingsExpo, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. Red Hat is the world's leading provider of open source software solutions, using a community-powered approach to reliable and high-performing cloud, Linux, middleware, storage and virtualization technologies. Red Hat also offers award-winning support, training, and consulting services. As the connective hub in a global network of enterprises, partners, a...
P2P RTC will impact the landscape of communications, shifting from traditional telephony style communications models to OTT (Over-The-Top) cloud assisted & PaaS (Platform as a Service) communication services. The P2P shift will impact many areas of our lives, from mobile communication, human interactive web services, RTC and telephony infrastructure, user federation, security and privacy implications, business costs, and scalability. In his session at Internet of @ThingsExpo, Robin Raymond, Chief Architect at Hookflash Inc., will walk through the shifting landscape of traditional telephone a...
SYS-CON Events announced today that Matrix.org has been named “Silver Sponsor” of Internet of @ThingsExpo, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. Matrix is an ambitious new open standard for open, distributed, real-time communication over IP. It defines a new approach for interoperable Instant Messaging and VoIP based on pragmatic HTTP APIs and WebRTC, and provides open source reference implementations to showcase and bootstrap the new standard. Our focus is on simplicity, security, and supporting the fullest feature set.
BSQUARE is a global leader of embedded software solutions. We enable smart connected systems at the device level and beyond that millions use every day and provide actionable data solutions for the growing Internet of Things (IoT) market. We empower our world-class customers with our products, services and solutions to achieve innovation and success. For more information, visit www.bsquare.com.
How do APIs and IoT relate? The answer is not as simple as merely adding an API on top of a dumb device, but rather about understanding the architectural patterns for implementing an IoT fabric. There are typically two or three trends: Exposing the device to a management framework Exposing that management framework to a business centric logic • Exposing that business layer and data to end users. This last trend is the IoT stack, which involves a new shift in the separation of what stuff happens, where data lives and where the interface lies. For instance, it’s a mix of architectural style...
SYS-CON Events announced today that SOA Software, an API management leader, will exhibit at SYS-CON's 15th International Cloud Expo®, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. SOA Software is a leading provider of API Management and SOA Governance products that equip business to deliver APIs and SOA together to drive their company to meet its business strategy quickly and effectively. SOA Software’s technology helps businesses to accelerate their digital channels with APIs, drive partner adoption, monetize their assets, and achieve a...
From a software development perspective IoT is about programming "things," about connecting them with each other or integrating them with existing applications. In his session at @ThingsExpo, Yakov Fain, co-founder of Farata Systems and SuranceBay, will show you how small IoT-enabled devices from multiple manufacturers can be integrated into the workflow of an enterprise application. This is a practical demo of building a framework and components in HTML/Java/Mobile technologies to serve as a platform that can integrate new devices as they become available on the market.
SYS-CON Events announced today that Utimaco will exhibit at SYS-CON's 15th International Cloud Expo®, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. Utimaco is a leading manufacturer of hardware based security solutions that provide the root of trust to keep cryptographic keys safe, secure critical digital infrastructures and protect high value data assets. Only Utimaco delivers a general-purpose hardware security module (HSM) as a customizable platform to easily integrate into existing software solutions, embed business logic and build s...
Connected devices are changing the way we go about our everyday life, from wearables to driverless cars, to smart grids and entire industries revolutionizing business opportunities through smart objects, capable of two-way communication. But what happens when objects are given an IP-address, and we rely on that connection, sometimes with our lives? How do we secure those vast data infrastructures and safe-keep the privacy of sensitive information? This session will outline how each and every connected device can uphold a core root of trust via a unique cryptographic signature – a “bir...
Internet of @ThingsExpo Silicon Valley announced on Thursday its first 12 all-star speakers and sessions for its upcoming event, which will take place November 4-6, 2014, at the Santa Clara Convention Center in California. @ThingsExpo, the first and largest IoT event in the world, debuted at the Javits Center in New York City in June 10-12, 2014 with over 6,000 delegates attending the conference. Among the first 12 announced world class speakers, IBM will present two highly popular IoT sessions, which will take place November 4-6, 2014 at the Santa Clara Convention Center in Santa Clara, Calif...
Almost everyone sees the potential of Internet of Things but how can businesses truly unlock that potential. The key will be in the ability to discover business insight in the midst of an ocean of Big Data generated from billions of embedded devices via Systems of Discover. Businesses will also need to ensure that they can sustain that insight by leveraging the cloud for global reach, scale and elasticity.
WebRTC defines no default signaling protocol, causing fragmentation between WebRTC silos. SIP and XMPP provide possibilities, but come with considerable complexity and are not designed for use in a web environment. In his session at Internet of @ThingsExpo, Matthew Hodgson, technical co-founder of the Matrix.org, will discuss how Matrix is a new non-profit Open Source Project that defines both a new HTTP-based standard for VoIP & IM signaling and provides reference implementations.

SUNNYVALE, Calif., Oct. 20, 2014 /PRNewswire/ -- Spansion Inc. (NYSE: CODE), a global leader in embedded systems, today added 96 new products to the Spansion® FM4 Family of flexible microcontrollers (MCUs). Based on the ARM® Cortex®-M4F core, the new MCUs boast a 200 MHz operating frequency and support a diverse set of on-chip peripherals for enhanced human machine interfaces (HMIs) and machine-to-machine (M2M) communications. The rich set of periphera...

SYS-CON Events announced today that Aria Systems, the recurring revenue expert, has been named "Bronze Sponsor" of SYS-CON's 15th International Cloud Expo®, which will take place on November 4-6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. Aria Systems helps leading businesses connect their customers with the products and services they love. Industry leaders like Pitney Bowes, Experian, AAA NCNU, VMware, HootSuite and many others choose Aria to power their recurring revenue business and deliver exceptional experiences to their customers.
The Internet of Things (IoT) is going to require a new way of thinking and of developing software for speed, security and innovation. This requires IT leaders to balance business as usual while anticipating for the next market and technology trends. Cloud provides the right IT asset portfolio to help today’s IT leaders manage the old and prepare for the new. Today the cloud conversation is evolving from private and public to hybrid. This session will provide use cases and insights to reinforce the value of the network in helping organizations to maximize their company’s cloud experience.
The Internet of Things (IoT) is making everything it touches smarter – smart devices, smart cars and smart cities. And lucky us, we’re just beginning to reap the benefits as we work toward a networked society. However, this technology-driven innovation is impacting more than just individuals. The IoT has an environmental impact as well, which brings us to the theme of this month’s #IoTuesday Twitter chat. The ability to remove inefficiencies through connected objects is driving change throughout every sector, including waste management. BigBelly Solar, located just outside of Boston, is trans...
SYS-CON Events announced today that Matrix.org has been named “Silver Sponsor” of Internet of @ThingsExpo, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. Matrix is an ambitious new open standard for open, distributed, real-time communication over IP. It defines a new approach for interoperable Instant Messaging and VoIP based on pragmatic HTTP APIs and WebRTC, and provides open source reference implementations to showcase and bootstrap the new standard. Our focus is on simplicity, security, and supporting the fullest feature set.
Predicted by Gartner to add $1.9 trillion to the global economy by 2020, the Internet of Everything (IoE) is based on the idea that devices, systems and services will connect in simple, transparent ways, enabling seamless interactions among devices across brands and sectors. As this vision unfolds, it is clear that no single company can accomplish the level of interoperability required to support the horizontal aspects of the IoE. The AllSeen Alliance, announced in December 2013, was formed with the goal to advance IoE adoption and innovation in the connected home, healthcare, education, aut...